Michael Erbach
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Diabetes Treatment and Management 8
- Diabetes Management and Research 7
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
- Surgery 2
- Pancreatic function and diabetes 1
- Co-authors
- Oliver Schnell (15 shared papers)Eberhard Standl (4 shared papers)Guido Freckmann (2 shared papers)Lutz Heinemann (2 shared papers)Rolf Hinzmann (2 shared papers)Ralph Ziegler (1 shared paper)Bernhard Kulzer (1 shared paper)Jaakko Tuomilehto (1 shared paper)
- Journals
- Journal of Diabetes Science and Technology (6 papers)Cardiology and Therapy (1 paper)Journal of Diabetes and its Complications (1 paper)Diabetes/Metabolism Research and Reviews (1 paper)Diabetes and Vascular Disease Research (1 paper)
- Partner nations
- GermanyUnited KingdomRomania
In The Last Decade
Michael Erbach
13 papers receiving 224 citations
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 168
- Cardiology and Cardiovascular Medicine 40
- Surgery 54
- Aging 2
- Biophysics 6
Countries citing papers authored by Michael Erbach
This map shows the geographic impact of Michael Erbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Erbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Erbach more than expected).
Fields of papers citing papers by Michael Erbach
This network shows the impact of papers produced by Michael Erbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Erbach. The network helps show where Michael Erbach may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Erbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 71 | |
| 2 | 2014 | 44 | |
| 3 | 2014 | 33 | |
| 4 | 2012 | 23 | |
| 5 | 2012 | 15 | |
| 6 | 2013 | 14 | |
| 7 | 2012 | 13 | |
| 8 | 2013 | 11 | |
| 9 | 2014 | 9 | |
| 10 | 2017 | 7 | |
| 11 | 2012 | 3 | |
| 12 | 2012 | 1 | |
| 13 | 2016 | 1 | |
| 14 | Combination therapy in diabetic neuropathy | 2016 | 0 |
| 15 | Neuropathy in chronic kidney disease | 2015 | 0 |
About Michael Erbach
Michael Erbach is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Nephrology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 245 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers), Diabetes and associated disorders (2 papers), Dialysis and Renal Disease Management (2 papers), Pancreatic function and diabetes (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (168 citations), Cardiology and Cardiovascular Medicine (40 citations), Surgery (54 citations), Aging (2 citations) and Biophysics (6 citations). Michael Erbach has collaborated with scholars based in Germany, United Kingdom and Romania. Frequent co-authors include Oliver Schnell, Eberhard Standl, Guido Freckmann, Lutz Heinemann, Rolf Hinzmann, Ralph Ziegler, Bernhard Kulzer, Jaakko Tuomilehto, Michael J. Theodorakis and Michael Hummel. Their work appears in journals such as Journal of Diabetes Science and Technology, Cardiology and Therapy, Journal of Diabetes and its Complications, Diabetes/Metabolism Research and Reviews and Diabetes and Vascular Disease Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.